ProQR Therapeutics (PRQR) Net Cash Flow Growth (3y) (2016 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -26.15% |
| Sep 30, 2022 | -80.86% |
| Jun 30, 2022 | -9.51% |
| Mar 31, 2022 | -20.12% |
| Dec 31, 2021 | 1,454.50% |
| Sep 30, 2021 | -42.25% |
| Jun 30, 2021 | 149.49% |
| Mar 31, 2021 | -2,917.74% |
| Dec 31, 2020 | -667.69% |
| Sep 30, 2020 | 4,552.11% |
| Jun 30, 2020 | -5.90% |
| Mar 31, 2020 | -50.11% |
| Dec 31, 2019 | 45.36% |
| Sep 30, 2019 | -831.48% |
| Dec 31, 2018 | 92.92% |
| Sep 30, 2018 | 2,272.56% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | 26.09% |
| Sep 30, 2017 | -99.28% |
| Mar 31, 2017 | 26.08% |
| Dec 31, 2016 | -144.90% |
| Sep 30, 2016 | 77.27% |